Latest Commercialisation Strategies News

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.

PMET Resources has endorsed NRW Holdings’ ALi® atmospheric leach process for producing battery-grade lithium carbonate, highlighting its economic and environmental advantages. NRW is advancing commercialisation with ongoing testing and development plans.

Iondrive Limited’s proprietary IONSolv™ process has independently achieved a 93.5% recovery rate for dysprosium from US commercial e-waste, vastly outperforming previous techno-economic assumptions and extending its rare earth extraction capabilities into heavy rare earths.

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.

LTR Pharma has secured a binding US telehealth commercialisation framework for its intranasal erectile dysfunction treatment ROXUS, committing to at least 150,000 prescriptions in the first year and granting exclusivity to Shed Holdings' platform.

InFocus Group Holdings is streamlining its software development operations by divesting Prodigy9 and consolidating under Onify, aiming for immediate cost savings and a leaner, AI-native delivery model.

Yojee Limited has secured Wayfinder Cargo Solutions as its second commercial customer for the MOSAIC freight forwarding platform, marking full operational coverage across all freight modes and directions ahead of its full commercial launch.

Tartana Minerals has kicked off an ambitious drilling program at its Tartana Copper Project aiming to more than double its contained copper resource beyond the existing open pit. Early drilling progress and operational upgrades signal a push toward expanding production and resource depth.

Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.

NoviqTech's Coralia has kicked off a comprehensive trial converting invasive Chinese Apple trees into biochar at its Great Barrier Reef project, aiming to validate carbon removal methods and support institutional partnerships.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.